NCT07391384 (Thymoquinone) is a NA clinical trial of group 1 xenograft hydrogel in Immediate Dental Implant Placement, sponsored by shaimaa hamdy.

Who is sponsoring NCT07391384?

NCT07391384 is sponsored by shaimaa hamdy.

What drugs are being tested in NCT07391384?

Interventions in NCT07391384: group 1 xenograft hydrogel, immediat implant placement wit TQ and bone graft hydrogel placement around implant.

What condition does NCT07391384 study?

NCT07391384 studies Immediate Dental Implant Placement, Jumping Gap, Primary Stability of the Implants.

Is NCT07391384 still recruiting?

NCT07391384 is currently not yet recruiting. Last updated 5 February 2026.

Last reviewed 2026-02-05 · How we verify

NCT07391384: Thymoquinone

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Thymoquinone Around Immediate Implant

Not yet recruiting NA Last updated 5 February 2026

What this trial tests

NA trial testing group 1 xenograft hydrogel in Immediate Dental Implant Placement in 44 participants. Not yet recruiting.

Timeline

21 January 2026

Primary endpoint
10 February 2026

11 April 2026

Quick facts

Lead sponsor	shaimaa hamdy
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	44
Start date	21 January 2026
Primary completion	10 February 2026
Estimated completion	11 April 2026

Drugs / interventions tested

group 1 xenograft hydrogel
immediat implant placement wit TQ and bone graft hydrogel placement around implant

Conditions studied

Immediate Dental Implant Placement — all drugs for Immediate Dental Implant Placement →
Jumping Gap — all drugs for Jumping Gap →
Primary Stability of the Implants — all drugs for Primary Stability of the Implants →

Sponsor

shaimaa hamdy — full company profile →

Who can join

Adults 20 to 55, any sex, with Immediate Dental Implant Placement or Jumping Gap. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

use of Thymoquinone hydrogel with bone graft in comparison to bone graft only around immediate implant-this hydrogel fill the jumping zone in comparison to using hydrogel bone graft only to increase primary stability and enhance osseointegration

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other shaimaa hamdy trials

Trials by the same sponsor.

NCT07157878 — Gingival Crevicular Fluid Oxidized Low-Density Lipoprotein Levels in Health and Stage III/IV Periodontitis · not yet recruiting
NCT07139392 — A Clinical Comparison of Connective Tissue Graft and Alb-PRF for Rebuilding Interdental Papilla · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07391384 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by shaimaa hamdy
Last refreshed: 5 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07391384.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing